Erratum: Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia

Erratum: Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia

Correction to: Gene Therapy advance online publication 14 January 2016; doi:10.1038/gt.2015.110 Following the online publication for this article, the authors noted that the funding information provided was incomplete. The full correct funding statement should appear as follows: Funded by ViroMed Co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gene therapy 2016-04, Vol.23 (4), p.399-399
Hauptverfasser: Kibbe, M R, Hirsch, A T, Mendelsohn, F O, Davies, M G, Pham, H, Saucedo, J, Marston, W, Pyun, W-B, Min, S-K, Peterson, B G, Comerota, A, Choi, D, Ballard, J, Bartow, R A, Losordo, D W, Sherman, W, Driver, V, Perin, E C
Format: Artikel
Sprache:eng
Schlagworte:
631/61/51/201
631/92/436/108
692/308/2779/109/1941
692/699/75/593/15/1939
Biomedical and Life Sciences
Biomedicine
Cell Biology
corrigendum
Erratum
Gene Expression
Gene Therapy
Human Genetics
Nanotechnology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Correction to: Gene Therapy advance online publication 14 January 2016; doi:10.1038/gt.2015.110 Following the online publication for this article, the authors noted that the funding information provided was incomplete. The full correct funding statement should appear as follows: Funded by ViroMed Co., Ltd, Seoul, Korea, and Reyon Pharmaceutical Co.
ISSN:0969-7128
1476-5462
DOI:10.1038/gt.2016.9